HomeCompareGILD vs SHW

GILD vs SHW: Dividend Comparison 2026

GILD yields 2.34% · SHW yields 1.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SHW wins by $280.1K in total portfolio value· pulled ahead in Year 3
10 years
GILD
GILD
● Live price
2.34%
Share price
$136.34
Annual div
$3.19
5Y div CAGR
17.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.1K
Annual income
$1,614.90
Full GILD calculator →
SHW
SHW
● Live price
1.00%
Share price
$315.90
Annual div
$3.17
5Y div CAGR
76.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$309.3K
Annual income
$185,821.41
Full SHW calculator →

Portfolio growth — GILD vs SHW

📍 SHW pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGILDSHW
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GILD + SHW cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GILD pays
SHW pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GILD
Annual income on $10K today (after 15% tax)
$198.88/yr
After 10yr DRIP, annual income (after tax)
$1,372.67/yr
SHW
Annual income on $10K today (after 15% tax)
$85.30/yr
After 10yr DRIP, annual income (after tax)
$157,948.20/yr
At 15% tax rate, SHW beats the other by $156,575.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GILD + SHW for your $10,000?

GILD: 50%SHW: 50%
100% SHW50/50100% GILD
Portfolio after 10yr
$169.2K
Annual income
$93,718.15/yr
Blended yield
55.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GILD right now

GILD
Analyst Ratings
37
Buy
20
Hold
1
Sell
Consensus: Buy
Price Target
$158.71
+16.4% upside vs current
Range: $105.00 — $180.00
Altman Z
4.1
Piotroski
8/9
SHW
Analyst Ratings
24
Buy
13
Hold
1
Sell
Consensus: Buy
Price Target
$396.83
+25.6% upside vs current
Range: $371.00 — $420.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GILD buys
0
SHW buys
0
No recent congressional trades found for GILD or SHW in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGILDSHW
Forward yield2.34%1.00%
Annual dividend / share$3.19$3.17
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR17.3%76.6%
Portfolio after 10y$29.1K$309.3K
Annual income after 10y$1,614.90$185,821.41
Total dividends collected$7.6K$277.6K
Payment frequencyquarterlyquarterly
SectorHealthcareMaterials
Analyst consensusBuyBuy
Analyst price target$158.71$396.83

Year-by-year: GILD vs SHW ($10,000, DRIP)

YearGILD PortfolioGILD Income/yrSHW PortfolioSHW Income/yrGap
1$10,974$274.45$10,877$177.21+$97.00GILD
2$12,073$330.19$11,957$318.14+$116.00GILD
3← crossover$13,316$398.20$13,371$577.20$55.00SHW
4$14,730$481.49$15,372$1,065.33$642.00SHW
5$16,345$583.87$18,470$2,021.46$2.1KSHW
6$18,199$710.26$23,771$4,008.63$5.6KSHW
7$20,340$866.96$33,950$8,515.19$13.6KSHW
8$22,826$1,062.22$56,399$20,072.16$33.6KSHW
9$25,731$1,306.80$115,381$55,033.62$89.7KSHW
10$29,147$1,614.90$309,279$185,821.41$280.1KSHW

GILD vs SHW: Complete Analysis 2026

GILDHealthcare

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.

Full GILD Calculator →

SHWMaterials

The Sherwin-Williams Company develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: The Americas Group, Consumer Brands Group, and Performance Coatings Group. The Americas Group segment offers architectural paints and coatings, and protective and marine products, as well as OEM product finishes and related products for architectural and industrial paint contractors, and do-it-yourself homeowners. The Consumer Brands Group segment supplies a portfolio of branded and private-label architectural paints, stains, varnishes, industrial products, wood finishes products, wood preservatives, applicators, corrosion inhibitors, aerosols, caulks, and adhesives to retailers and distributors. The Performance Coatings Group segment develops and sells industrial coatings for wood finishing and general industrial applications, automotive refinish products, protective and marine coatings, coil coatings, packaging coatings, and performance-based resins and colorants. It serves retailers, dealers, jobbers, licensees, and other third-party distributors through its branches and direct sales staff, as well as through outside sales representatives. The company has operations primarily in the North and South America, the Caribbean, Europe, Asia, and Australia. As of February 17, 2022, it operated approximately 5,000 company-operated stores and facilities. The Sherwin-Williams Company was founded in 1866 and is headquartered in Cleveland, Ohio.

Full SHW Calculator →
📬

Get this GILD vs SHW comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GILD vs SCHDGILD vs JEPIGILD vs OGILD vs KOGILD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.